Wandercraft unveils Calvin, new industrial humanoid, and Renault partnership - The Robot Report

Wandercraft, a French robotics company founded in 2012 with a mission to aid people with severe mobility impairments, has unveiled its first humanoid robot named Calvin. Developed in just 40 days using technology from its exoskeleton products, Calvin is designed primarily for industrial applications. This launch coincides with Renault Group’s minority investment in Wandercraft, aimed at advancing Calvin as a next-generation industrial robot to alleviate workers from physically demanding tasks, improve ergonomics, and boost productivity. Renault will also support commercialization efforts by leveraging its expertise in cost reduction and scaling, facilitating broader market access for Wandercraft’s robotics, including its new exoskeleton, Eve. Wandercraft’s flagship product, the Atalante X exoskeleton, is a self-stabilizing device used in nearly 100 rehabilitation centers worldwide, enabling patients with spinal cord injuries and stroke to walk and relearn natural motion. It features ActiveBalance mode and 12 degrees of freedom for hips, knees, and ankles, offering benefits for both patients and therapists. The device has FDA clearance and CE marking for various conditions. Building on this success, Wandercraft recently introduced a Personal Exoskeleton prototype designed for everyday use in home and community settings, currently undergoing clinical trials. This system also features a fully powered lower body and dynamic walking control, aiming to enhance personal mobility outside clinical environments.